Overview

Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.

Status:
Completed

Trial end date:
2007-02-01

Target enrollment:

Participant gender:

Summary

To investigate the efficacy of ciclesonide MDI either as once daily or twice daily in patients with mild to moderate asthma, who have not previously been treated with an inhaled corticosteroid.

Phase:

Phase 3

Details

Lead Sponsor:

Sanofi

Treatments:

Ciclesonide